Carlos Abraira, MD
Co-Chairman, VA Diabetes Trial Professor of Medicine - VAMC
|
| |
NO CONFERENCE - THANKSGIVING HOLIDAY
November 25, 2009
|
| |
Genetic Basis of Kidney Disease Burden Among Africian Americans
Rulan Parekh, M.D., M.S.
December 2, 2009
|
| |
William Harrington Lecture
December 9, 2009
|
| |
Worldwide Evolution of Resistance in Gram Negatives
Laurent Poirel, PhD
December 16, 2009
|
| |
NO CONFERENCE - CHRISTMAS HOLIDAY
December 23, 2009
|
| |
NO CONFERENCE - NEW YEAR'S HOLIDAY
December 30, 2009
|
| |
To Be Announced
Paul Martin, MD
January 20, 2010
|
| |
Atrial Fibrillation: Spectrum and Management Strategies
Robert J. Myerburg, M.D.
January 27, 2010
|
| |
To Be Announced
Silvia Munoz-Price, MD
March 3, 2010
|
| |
To Be Announced
Christopher O'Brien M.D.
March 10, 2010
|
| |
To Be Announced
Flavia Mendes, M.D.
April 21, 2010
|
Click here
for Archived Events

|
|
Final VADT Results: Comparisons with Recent Trials
Upon completion of this activity, physicians should be able to: 1. Target glycemic control according to individual characteristics of type 2 diabetes patients. 2. Compare recent released trials: VADT, ADVANCE, and ACCORD. 3. Evaluate retrospective evidence, as well as learn about the "memory effect" as demonstrated by long-term follow-up of DCCT (EDIC) and UKPDS follow up findings.
|
|
|
|